ETF · holdings as filed 2026-05-31

What's inside FBIOX?

Select Biotechnology Portfolio
Holdings
193
positions in the fund
Top 10
45%
of fund assets
Expense ratio
0.62%
net, per year
Fund size
$5B
total net assets
Sectors tap a row to see its top 10 holdings
Top holdings — Health Care
Your 10 largest positions in this sector
1
K
KRYSKRYSTAL BIOTECH INC
10.23%
2
A
ABBVABBVIE INC
8.92%
3
A
AMGNAMGEN INC
6.31%
4
G
GILDGILEAD SCIENCES INC
4.66%
5
A
ALNYALNYLAM PHARMACEUTICALS INC
2.84%
6
P
PRAXPRAXIS PRECISION MEDICINES I
2.39%
7
I
INSMINSMED INC
2.18%
8
A
ARGXARGENX SE - ADR
2.17%
9
A
ASNDASCENDIS PHARMA A/S
1.98%
10
R
RVMDREVOLUTION MEDICINES INC
1.95%
Geography tap a row to see its top 10 holdings
Top holdings — United States
Your 10 largest positions in this country
1
K
KRYSKRYSTAL BIOTECH INC
10.23%
2
A
ABBVABBVIE INC
8.92%
3
A
AMGNAMGEN INC
6.31%
4
G
GILDGILEAD SCIENCES INC
4.66%
5
A
ALNYALNYLAM PHARMACEUTICALS INC
2.84%
6
P
PRAXPRAXIS PRECISION MEDICINES I
2.39%
7
I
INSMINSMED INC
2.18%
8
R
RVMDREVOLUTION MEDICINES INC
1.95%
9
S
SRRKSCHOLAR ROCK HOLDING CORP
1.49%
10
N
NTRANATERA INC
1.36%
Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold FBIOX alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-05-31); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.